Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,071 INR | -2.65% | -7.66% | +50.34% |
Sales 2024 * | 8.45B 101M | Sales 2025 * | 10.78B 129M | Capitalization | 54.33B 651M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.87M | Net income 2025 * | 1.42B 17.03M | EV / Sales 2024 * | 6.31 x |
Net cash position 2024 * | 1.06B 12.64M | Net cash position 2025 * | 1.2B 14.33M | EV / Sales 2025 * | 4.93 x |
P/E ratio 2024 * |
59.4
x | P/E ratio 2025 * |
38.3
x | Employees | 838 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
1 day | -2.65% | ||
1 week | -7.66% | ||
Current month | +2.52% | ||
1 month | +3.38% | ||
3 months | +46.79% | ||
6 months | +124.26% | ||
Current year | +50.34% |
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | Dec. 15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1,071 | -2.65% | 40,265 |
24-04-16 | 1,100 | +0.13% | 295,899 |
24-04-15 | 1,099 | +0.92% | 319,745 |
24-04-12 | 1,089 | -6.13% | 354,926 |
24-04-10 | 1,160 | -1.78% | 327,236 |
Delayed Quote NSE India S.E., April 18, 2024 at 07:43 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.34% | 667M | |
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- ORCHPHARMA Stock